Anxiety and Panic Disorders Drugs are two kinds of drugs which are usually used in respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, infection, neuroscience, and gastrointestinal.
During 2017, the anxiety and panic disorders antidepressant drugs segment contributed to the majority of the revenue to the overall market and will continue to be the major revenue contributor to the market during the next four years as well. The introduction of newer selective serotonin reuptake inhibitor (SSRIs) with more safer side effects is driving the market segment’s growth in the coming years. Brintellix was approved by the US FDA in September 2013 for the treatment of depression.
The global Anxiety and Panic Disorders Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anxiety and Panic Disorders Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anxiety and Panic Disorders Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anxiety and Panic Disorders Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anxiety and Panic Disorders Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Roche
AstraZeneca
Eli Lilly
GlaxoSmithKline
Pfizer
Azevan Pharmaceuticals
Baxter
Bristol-Myers Squibb
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Antidepressant Drugs
Anxiolytic Drugs
Segment by Application
Hospitals
Clinics
During 2017, the anxiety and panic disorders antidepressant drugs segment contributed to the majority of the revenue to the overall market and will continue to be the major revenue contributor to the market during the next four years as well. The introduction of newer selective serotonin reuptake inhibitor (SSRIs) with more safer side effects is driving the market segment’s growth in the coming years. Brintellix was approved by the US FDA in September 2013 for the treatment of depression.
The global Anxiety and Panic Disorders Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anxiety and Panic Disorders Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anxiety and Panic Disorders Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anxiety and Panic Disorders Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anxiety and Panic Disorders Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Roche
AstraZeneca
Eli Lilly
GlaxoSmithKline
Pfizer
Azevan Pharmaceuticals
Baxter
Bristol-Myers Squibb
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Antidepressant Drugs
Anxiolytic Drugs
Segment by Application
Hospitals
Clinics
Table of Contents
Executive Summary
1 Industry Overview of Anxiety and Panic Disorders Drugs
1.1 Definition of Anxiety and Panic Disorders Drugs
1.2 Anxiety and Panic Disorders Drugs Segment by Type
1.2.1 Global Anxiety and Panic Disorders Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Antidepressant Drugs
1.2.3 Anxiolytic Drugs
1.3 Anxiety and Panic Disorders Drugs Segment by Applications
1.3.1 Global Anxiety and Panic Disorders Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Anxiety and Panic Disorders Drugs Overall Market
1.4.1 Global Anxiety and Panic Disorders Drugs Revenue (2014-2025)
1.4.2 Global Anxiety and Panic Disorders Drugs Production (2014-2025)
1.4.3 North America Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.4 Europe Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.5 China Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.6 Japan Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.8 India Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Anxiety and Panic Disorders Drugs
2.3 Manufacturing Process Analysis of Anxiety and Panic Disorders Drugs
2.4 Industry Chain Structure of Anxiety and Panic Disorders Drugs
3 Development and Manufacturing Plants Analysis of Anxiety and Panic Disorders Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Anxiety and Panic Disorders Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Anxiety and Panic Disorders Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Anxiety and Panic Disorders Drugs Production and Capacity Analysis
4.2 Anxiety and Panic Disorders Drugs Revenue Analysis
4.3 Anxiety and Panic Disorders Drugs Price Analysis
4.4 Market Concentration Degree
5 Anxiety and Panic Disorders Drugs Regional Market Analysis
5.1 Anxiety and Panic Disorders Drugs Production by Regions
5.1.1 Global Anxiety and Panic Disorders Drugs Production by Regions
5.1.2 Global Anxiety and Panic Disorders Drugs Revenue by Regions
5.2 Anxiety and Panic Disorders Drugs Consumption by Regions
5.3 North America Anxiety and Panic Disorders Drugs Market Analysis
5.3.1 North America Anxiety and Panic Disorders Drugs Production
5.3.2 North America Anxiety and Panic Disorders Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Anxiety and Panic Disorders Drugs Import and Export
5.4 Europe Anxiety and Panic Disorders Drugs Market Analysis
5.4.1 Europe Anxiety and Panic Disorders Drugs Production
5.4.2 Europe Anxiety and Panic Disorders Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Anxiety and Panic Disorders Drugs Import and Export
5.5 China Anxiety and Panic Disorders Drugs Market Analysis
5.5.1 China Anxiety and Panic Disorders Drugs Production
5.5.2 China Anxiety and Panic Disorders Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Anxiety and Panic Disorders Drugs Import and Export
5.6 Japan Anxiety and Panic Disorders Drugs Market Analysis
5.6.1 Japan Anxiety and Panic Disorders Drugs Production
5.6.2 Japan Anxiety and Panic Disorders Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Anxiety and Panic Disorders Drugs Import and Export
5.7 Southeast Asia Anxiety and Panic Disorders Drugs Market Analysis
5.7.1 Southeast Asia Anxiety and Panic Disorders Drugs Production
5.7.2 Southeast Asia Anxiety and Panic Disorders Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Anxiety and Panic Disorders Drugs Import and Export
5.8 India Anxiety and Panic Disorders Drugs Market Analysis
5.8.1 India Anxiety and Panic Disorders Drugs Production
5.8.2 India Anxiety and Panic Disorders Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Anxiety and Panic Disorders Drugs Import and Export
6 Anxiety and Panic Disorders Drugs Segment Market Analysis (by Type)
6.1 Global Anxiety and Panic Disorders Drugs Production by Type
6.2 Global Anxiety and Panic Disorders Drugs Revenue by Type
6.3 Anxiety and Panic Disorders Drugs Price by Type
7 Anxiety and Panic Disorders Drugs Segment Market Analysis (by Application)
7.1 Global Anxiety and Panic Disorders Drugs Consumption by Application
7.2 Global Anxiety and Panic Disorders Drugs Consumption Market Share by Application (2014-2019)
8 Anxiety and Panic Disorders Drugs Major Manufacturers Analysis
8.1 Roche
8.1.1 Roche Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.1.2 Roche Product Introduction, Application and Specification
8.1.3 Roche Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AstraZeneca
8.2.1 AstraZeneca Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.2.2 AstraZeneca Product Introduction, Application and Specification
8.2.3 AstraZeneca Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Eli Lilly
8.3.1 Eli Lilly Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.3.2 Eli Lilly Product Introduction, Application and Specification
8.3.3 Eli Lilly Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 GlaxoSmithKline
8.4.1 GlaxoSmithKline Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.4.2 GlaxoSmithKline Product Introduction, Application and Specification
8.4.3 GlaxoSmithKline Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pfizer
8.5.1 Pfizer Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.5.2 Pfizer Product Introduction, Application and Specification
8.5.3 Pfizer Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Azevan Pharmaceuticals
8.6.1 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.6.2 Azevan Pharmaceuticals Product Introduction, Application and Specification
8.6.3 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Baxter
8.7.1 Baxter Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.7.2 Baxter Product Introduction, Application and Specification
8.7.3 Baxter Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bristol-Myers Squibb
8.8.1 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.8.3 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Anxiety and Panic Disorders Drugs Market
9.1 Global Anxiety and Panic Disorders Drugs Market Trend Analysis
9.1.1 Global Anxiety and Panic Disorders Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Anxiety and Panic Disorders Drugs Regional Market Trend
9.2.1 North America Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.2 Europe Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.3 China Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.4 Japan Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.5 Southeast Asia Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.6 India Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.3 Anxiety and Panic Disorders Drugs Market Trend (Product Type)
9.4 Anxiety and Panic Disorders Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Anxiety and Panic Disorders Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Executive Summary
1 Industry Overview of Anxiety and Panic Disorders Drugs
1.1 Definition of Anxiety and Panic Disorders Drugs
1.2 Anxiety and Panic Disorders Drugs Segment by Type
1.2.1 Global Anxiety and Panic Disorders Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Antidepressant Drugs
1.2.3 Anxiolytic Drugs
1.3 Anxiety and Panic Disorders Drugs Segment by Applications
1.3.1 Global Anxiety and Panic Disorders Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Anxiety and Panic Disorders Drugs Overall Market
1.4.1 Global Anxiety and Panic Disorders Drugs Revenue (2014-2025)
1.4.2 Global Anxiety and Panic Disorders Drugs Production (2014-2025)
1.4.3 North America Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.4 Europe Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.5 China Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.6 Japan Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
1.4.8 India Anxiety and Panic Disorders Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Anxiety and Panic Disorders Drugs
2.3 Manufacturing Process Analysis of Anxiety and Panic Disorders Drugs
2.4 Industry Chain Structure of Anxiety and Panic Disorders Drugs
3 Development and Manufacturing Plants Analysis of Anxiety and Panic Disorders Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Anxiety and Panic Disorders Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Anxiety and Panic Disorders Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Anxiety and Panic Disorders Drugs Production and Capacity Analysis
4.2 Anxiety and Panic Disorders Drugs Revenue Analysis
4.3 Anxiety and Panic Disorders Drugs Price Analysis
4.4 Market Concentration Degree
5 Anxiety and Panic Disorders Drugs Regional Market Analysis
5.1 Anxiety and Panic Disorders Drugs Production by Regions
5.1.1 Global Anxiety and Panic Disorders Drugs Production by Regions
5.1.2 Global Anxiety and Panic Disorders Drugs Revenue by Regions
5.2 Anxiety and Panic Disorders Drugs Consumption by Regions
5.3 North America Anxiety and Panic Disorders Drugs Market Analysis
5.3.1 North America Anxiety and Panic Disorders Drugs Production
5.3.2 North America Anxiety and Panic Disorders Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Anxiety and Panic Disorders Drugs Import and Export
5.4 Europe Anxiety and Panic Disorders Drugs Market Analysis
5.4.1 Europe Anxiety and Panic Disorders Drugs Production
5.4.2 Europe Anxiety and Panic Disorders Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Anxiety and Panic Disorders Drugs Import and Export
5.5 China Anxiety and Panic Disorders Drugs Market Analysis
5.5.1 China Anxiety and Panic Disorders Drugs Production
5.5.2 China Anxiety and Panic Disorders Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Anxiety and Panic Disorders Drugs Import and Export
5.6 Japan Anxiety and Panic Disorders Drugs Market Analysis
5.6.1 Japan Anxiety and Panic Disorders Drugs Production
5.6.2 Japan Anxiety and Panic Disorders Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Anxiety and Panic Disorders Drugs Import and Export
5.7 Southeast Asia Anxiety and Panic Disorders Drugs Market Analysis
5.7.1 Southeast Asia Anxiety and Panic Disorders Drugs Production
5.7.2 Southeast Asia Anxiety and Panic Disorders Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Anxiety and Panic Disorders Drugs Import and Export
5.8 India Anxiety and Panic Disorders Drugs Market Analysis
5.8.1 India Anxiety and Panic Disorders Drugs Production
5.8.2 India Anxiety and Panic Disorders Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Anxiety and Panic Disorders Drugs Import and Export
6 Anxiety and Panic Disorders Drugs Segment Market Analysis (by Type)
6.1 Global Anxiety and Panic Disorders Drugs Production by Type
6.2 Global Anxiety and Panic Disorders Drugs Revenue by Type
6.3 Anxiety and Panic Disorders Drugs Price by Type
7 Anxiety and Panic Disorders Drugs Segment Market Analysis (by Application)
7.1 Global Anxiety and Panic Disorders Drugs Consumption by Application
7.2 Global Anxiety and Panic Disorders Drugs Consumption Market Share by Application (2014-2019)
8 Anxiety and Panic Disorders Drugs Major Manufacturers Analysis
8.1 Roche
8.1.1 Roche Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.1.2 Roche Product Introduction, Application and Specification
8.1.3 Roche Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AstraZeneca
8.2.1 AstraZeneca Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.2.2 AstraZeneca Product Introduction, Application and Specification
8.2.3 AstraZeneca Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Eli Lilly
8.3.1 Eli Lilly Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.3.2 Eli Lilly Product Introduction, Application and Specification
8.3.3 Eli Lilly Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 GlaxoSmithKline
8.4.1 GlaxoSmithKline Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.4.2 GlaxoSmithKline Product Introduction, Application and Specification
8.4.3 GlaxoSmithKline Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pfizer
8.5.1 Pfizer Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.5.2 Pfizer Product Introduction, Application and Specification
8.5.3 Pfizer Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Azevan Pharmaceuticals
8.6.1 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.6.2 Azevan Pharmaceuticals Product Introduction, Application and Specification
8.6.3 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Baxter
8.7.1 Baxter Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.7.2 Baxter Product Introduction, Application and Specification
8.7.3 Baxter Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bristol-Myers Squibb
8.8.1 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Production Sites and Area Served
8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.8.3 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Anxiety and Panic Disorders Drugs Market
9.1 Global Anxiety and Panic Disorders Drugs Market Trend Analysis
9.1.1 Global Anxiety and Panic Disorders Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Anxiety and Panic Disorders Drugs Regional Market Trend
9.2.1 North America Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.2 Europe Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.3 China Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.4 Japan Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.5 Southeast Asia Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.2.6 India Anxiety and Panic Disorders Drugs Forecast 2019-2025
9.3 Anxiety and Panic Disorders Drugs Market Trend (Product Type)
9.4 Anxiety and Panic Disorders Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Anxiety and Panic Disorders Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
